Search Login Register

withaferin A Summary

23 relevant articles (2 outcomes, 1 trials/studies) found for this Bio-Agent

Description: isolated from leaves of Withania somnifera Dun.; structure

Also Known As: 5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dienoic acid delta-lactone; (4 beta,5 beta,6 beta,22R)-5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta- 2,24-dien-26-oic acid, delta-lactone

Key Diseases for which withaferin A is Relevant

  1. Chromosome Breakage : 1 outcome in 1 result
  2. Infection : 1 outcome in 1 result
  3. Dislocations : 1 outcome in 1 result
  4. Chromosome Aberrations (Chromosome Abnormalities) : 1 outcome in 1 result
  5. Melanoma (Melanoma, Malignant) : 1 study in 2 results
Show All >>

Drugs Related to withaferin A

  1. 9,10-Dimethyl-1,2-benzanthracene (DMBA)
  2. bortezomib (Velcade)
  3. wedelolactone
  4. NF-kappa B (NF-kB)
  5. Withanolides
  6. Proteasome Endopeptidase Complex (Proteasome)
  7. Reactive Oxygen Species (Oxygen Radicals)
  8. Vimentin
  9. Messenger RNA (mRNA)
  10. Cysteine (L-Cysteine)
Show All >>

Therapies Related to withaferin A

  1. Heterologous Transplantation (Xenotransplantation)
  2. Ayurvedic Medicine (Siddha Medicine)
  3. Induced Hyperthermia (Thermotherapy)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.